Study of Estrogen Receptor-Mediated PGx-eQTLs Identifies Genetic Determinants of Breast Cancer Endocrine Therapy Response
Martin Meng, Arnab Ghosh, Huanyao Gao, John August, Shreya Indulkar, Meijie Wang, Xue Wang, Zhuyao Wang, Asadoor Amirkhani Namagerdi, Richard M. Weinshilboum, James N. Ingle, Liewei Wang · 2026
Read Study of Estrogen Receptor-Mediated PGx-eQTLs Identifies Genetic Determinants of Breast Cancer Endocrine Therapy Response by Martin Meng, Arnab Ghosh, Huanyao Gao, John August, Shreya Indulkar, Meijie Wang, Xue Wang, Zhuyao Wang, Asadoor Amirkhani Namagerdi, Richard M. Weinshilboum, James N. Ingle, Liewei Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13607051.txt.
Description
Martin Meng and a large team hunt gene marks that set how breast cancer cells heed hormone cure. Their study appeared in twenty twenty-six. Hormone cure is the base cure for cancers that feed on estrogen, yet gene past shifts who gains. Cell lines were dosed with estrogen and a block drug, and gene use shifts were mapped by gene form.
Two mark pairs tied to fate after cure, with swings from worse to better free-span by gene form. Two more genes showed like cure-tied fate and risk shifts. Lab checks in a fresh cell set proved the gene-form aim of the marks. The team offers them as tools for fit cure picks.
Catalog record
| CREATOR | Martin Meng, Arnab Ghosh, Huanyao Gao, John August, Shreya Indulkar, Meijie Wang, Xue Wang, Zhuyao Wang, Asadoor Amirkhani Namagerdi, Richard M. Weinshilboum, James N. Ingle, Liewei Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 41 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |